Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004479
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-10-18
Brief Title:
Randomized Study of Midodrine an Alpha Adrenergic Agonist in Patients With Neurally Mediated Syncope
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Office of Rare Diseases ORD
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2004-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OBJECTIVES
Determine the efficacy of midodrine a selective alpha 1 adrenergic agonist in preventing neurally mediated syncope
Determine the efficacy of midodrine a selective alpha 1 adrenergic agonist in preventing neurally mediated syncope
Detailed Description:
PROTOCOL OUTLINE This is a randomized double-blind crossover placebo-controlled study
On day one patients receive either midodrine or placebo On day three patients receive the opposite drug
On day one patients receive either midodrine or placebo On day three patients receive the opposite drug
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MTS-GCO-97-160NE | None | None | None |
| ROBERTS-MTS-GCO-97-160NE | None | None | None |